Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|August 1, 2004
- Volume 0 0
Association Seeks Donations for Pharmacy Scholarships
Advertisement
The National Community PharmacistsAssociation (NCPA) Foundation isseeking donations for its Annual ScholarshipFundraising Auction. Last year'sauction helped raise $15,000 for studentscholarships. Antique pharmacyitems are of particular interest.
The auction will be held in conjunctionwith NCPA's 106th AnnualConvention and Trade Exposition,October 9-13 in Boston, Mass. ContactFoundation Trustee Joe Mosso [email protected] for additionalinformation.
Articles in this issue
about 22 years ago
Training Reinforcementsabout 22 years ago
Hospice Care: Pharmacotherapy for Comfort Careabout 22 years ago
Finger Pointing by Doctor and Pharmacist Over Refillsabout 22 years ago
Pharmacist's Counseling Guide for Obesity Managementabout 22 years ago
A Gaining Trend: Obesity in the United Statesabout 22 years ago
Fructose May Lead to Overeatingabout 22 years ago
Obesity Rates Climb in the Elderlyabout 22 years ago
Food Regulations Are Proposed Abroadabout 22 years ago
Weight Loss in Obese Women Improves Lung Functionabout 22 years ago
Obesity Hinders Sexual FunctioningAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Belzutifan Plus Lenvatinib for Advanced Renal Cell Carcinoma After Immunotherapy
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
4
FDA Approves Insulin Efsitora, Once-Weekly Basal Insulin Injection for Adults With T2D
5